Works matching DE "THERAPEUTIC use of protease inhibitors"
Results: 705
Overview and Management of Cardiac and Pulmonary Adverse Events in Patients With Relapsed and/or Refractory Multiple Myeloma Treated With Single-Agent Carfilzomib: Page 2 of 2.
- Published in:
- Oncology (08909091), 2013, v. 27, p. 1
- By:
- Publication type:
- Article
Overview and Management of Cardiac and Pulmonary Adverse Events in Patients With Relapsed and/or Refractory Multiple Myeloma Treated With Single-Agent Carfilzomib.
- Published in:
- Oncology (08909091), 2013, v. 27, p. 1
- By:
- Publication type:
- Article
Managing Adverse Events of Multiple Myeloma and Anti--Multiple Myeloma Treatment: A Perspective on Carfilzomib.
- Published in:
- Oncology (08909091), 2013, v. 27, p. 1
- By:
- Publication type:
- Article
Incidence and Management of Renal Adverse Events in Patients With Relapsed and/or Refractory Multiple Myeloma Treated With Single-Agent Carfilzomib.
- Published in:
- Oncology (08909091), 2013, v. 27, p. 1
- By:
- Publication type:
- Article
Incidence and Management of Renal Adverse Events in Patients With Relapsed and/or Refractory Multiple Myeloma Treated With Single-Agent Carfilzomib: Page 2 of 2.
- Published in:
- Oncology (08909091), 2013, v. 27, p. 1
- By:
- Publication type:
- Article
Recruitment and Retention of Diverse Populations in Antiretroviral Clinical Trials: Practical Applications from the Gender, Race And Clinical Experience Study.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Bone-Targeted Therapies in Cancer-Induced Bone Disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The Proteasome and Myeloma-Associated Bone Disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Incremental net benefit of lipid-lowering therapy with PCSK9 inhibitors: a systematic review and meta-analysis of cost-utility studies.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 3, p. 351, doi. 10.1007/s00228-021-03242-6
- By:
- Publication type:
- Article
Pharmacokinetics and safety of glecaprevir and pibrentasvir in HCV-negative subjects with hepatic impairment.
- Published in:
- European Journal of Clinical Pharmacology, 2019, v. 75, n. 2, p. 217, doi. 10.1007/s00228-018-2576-4
- By:
- Publication type:
- Article
Expression and localization of maspin in cervical cancer and its role in tumor progression and lymphangiogenesis.
- Published in:
- Archives of Gynecology & Obstetrics, 2014, v. 289, n. 2, p. 373, doi. 10.1007/s00404-013-2988-4
- By:
- Publication type:
- Article
Therapeutics: New drugs hit the target.
- Published in:
- Nature, 2011, v. 474, n. 7350, p. S5, doi. 10.1038/474S5a
- By:
- Publication type:
- Article
Study shows 50% failure for protease inhibitors.
- Published in:
- Medical Laboratory Observer (MLO), 1997, v. 29, n. 11, p. 8
- By:
- Publication type:
- Article
Evaluation of the Side Effects of Antiretroviral Treatment.
- Published in:
- Mediterranean Journal of Infection, Microbes & Antimicrobials, 2018, p. 1, doi. 10.4274/mjima.2018.11
- By:
- Publication type:
- Article
From Triple- to Penta-Exposed Multiple Myeloma: A Real-World Study in a Medicare Population.
- Published in:
- Oncology & Therapy, 2024, v. 12, n. 3, p. 565, doi. 10.1007/s40487-024-00291-6
- By:
- Publication type:
- Article
Surface structured liposomes for site specific delivery of an antiviral agent-indinavir.
- Published in:
- Journal of Drug Targeting, 2011, v. 19, n. 4, p. 258, doi. 10.3109/1061186X.2010.499460
- By:
- Publication type:
- Article
High Detection Rate of HIV Drug Resistance Mutations among Patients Who Fail Combined Antiretroviral Therapy in Manaus, Brazil.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/5567332
- By:
- Publication type:
- Article
Active Learning and the Potential of Neural Networks Accelerate Molecular Screening for the Design of a New Molecule Effective against SARS-CoV-2.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/6696012
- By:
- Publication type:
- Article
Antitumor Effect of Inula viscosa Extracts on DMBA-Induced Skin Carcinoma Are Mediated by Proteasome Inhibition.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/6687589
- By:
- Publication type:
- Article
Cytochrome 2B6 polymorphism and efavirenz-induced central nervous system symptoms : a substudy of the ANRS ALIZE trial.
- Published in:
- HIV Medicine, 2017, v. 18, n. 8, p. 537, doi. 10.1111/hiv.12488
- By:
- Publication type:
- Article
Fibroblast growth factor 23: associations with antiretroviral therapy in patients co-infected with HIV and hepatitis C.
- Published in:
- HIV Medicine, 2016, v. 17, n. 5, p. 373, doi. 10.1111/hiv.12305
- By:
- Publication type:
- Article
Efficacy of etravirine combined with darunavir or other ritonavir-boosted protease inhibitors in HIV-1-infected patients: an observational study using pooled European cohort data.
- Published in:
- HIV Medicine, 2015, v. 16, n. 5, p. 297, doi. 10.1111/hiv.12218
- By:
- Publication type:
- Article
A randomized controlled trial of single-class maintenance therapy with abacavir/lamivudine/zidovudine after standard triple antiretroviral induction therapy: final 96-week results from the FREE study.
- Published in:
- HIV Medicine, 2015, v. 16, n. 2, p. 122, doi. 10.1111/hiv.12186
- By:
- Publication type:
- Article
Evaluation of progressive multifocal leukoencephalopathy treatments in a Spanish cohort of HIV-infected patients: do protease inhibitors improve survival regardless of central nervous system penetration-effectiveness ( CPE) score?
- Published in:
- HIV Medicine, 2013, v. 14, n. 5, p. 321, doi. 10.1111/hiv.12008
- By:
- Publication type:
- Article
Effectiveness and safety of protease inhibitor-based regimens in HIV-infected Thai children failing first-line treatment.
- Published in:
- HIV Medicine, 2013, v. 14, n. 4, p. 226, doi. 10.1111/j.1468-1293.2012.01061.x
- By:
- Publication type:
- Article
HIV-2 infection in Providence, Rhode Island from 2002 to 2011 HIV-2 infection in Providence, Rhode Island from 2002 to 2011.
- Published in:
- HIV Medicine, 2013, v. 14, n. 2, p. 115, doi. 10.1111/j.1468-1293.2012.01025.x
- By:
- Publication type:
- Article
2.0 Recommendations and auditable outcomes.
- Published in:
- HIV Medicine, 2012, v. 13, p. 11, doi. 10.1111/j.1468-1293.2012.01029_3.x
- Publication type:
- Article
6.0 Supporting patients on therapy.
- Published in:
- HIV Medicine, 2012, v. 13, p. 35, doi. 10.1111/j.1468-1293.2012.01029_7.x
- Publication type:
- Article
7.0 Managing virological failure.
- Published in:
- HIV Medicine, 2012, v. 13, p. 47, doi. 10.1111/j.1468-1293.2012.01029_8.x
- Publication type:
- Article
Long-term beneficial effect of protease inhibitors on the intrinsic apoptosis of peripheral blood mononuclear cells in HIV-infected patients.
- Published in:
- HIV Medicine, 2012, v. 13, n. 8, p. 469, doi. 10.1111/j.1468-1293.2012.00999.x
- By:
- Publication type:
- Article
Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis.
- Published in:
- HIV Medicine, 2012, v. 13, n. 8, p. 453, doi. 10.1111/j.1468-1293.2012.00996.x
- By:
- Publication type:
- Article
Body fat distribution in HIV-infected patients treated for 96 weeks with darunavir/ritonavir monotherapy versus darunavir/ritonavir plus nucleoside reverse transcriptase inhibitors: the MONOI-ANRS136 Substudy Body fat distribution in HIV-infected patients treated for 96 weeks with darunavir/ritonavir monotherapy versus darunavir/ritonavir plus nucleoside reverse transcriptase inhibitors: the MONOI-ANRS136 Substudy
- Published in:
- HIV Medicine, 2012, v. 13, n. 8, p. 505, doi. 10.1111/j.1468-1293.2012.01004.x
- By:
- Publication type:
- Article
Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women.
- Published in:
- HIV Medicine, 2011, v. 12, n. 9, p. 570, doi. 10.1111/j.1468-1293.2011.00927.x
- By:
- Publication type:
- Article
Therapeutic drug monitoring of lopinavir/ritonavir in pregnancy.
- Published in:
- HIV Medicine, 2011, v. 12, n. 3, p. 166, doi. 10.1111/j.1468-1293.2010.00865.x
- By:
- Publication type:
- Article
Bone mineral density changes in protease inhibitor-sparing vs. nucleoside reverse transcriptase inhibitor-sparing highly active antiretroviral therapy: data from a randomized trial.
- Published in:
- HIV Medicine, 2011, v. 12, n. 3, p. 157, doi. 10.1111/j.1468-1293.2010.00864.x
- By:
- Publication type:
- Article
The HIV protease inhibitor lopinavir/ritonavir (Kaletra) alters the growth, differentiation and proliferation of primary gingival epithelium.
- Published in:
- HIV Medicine, 2011, v. 12, n. 3, p. 145, doi. 10.1111/j.1468-1293.2010.00863.x
- By:
- Publication type:
- Article
Assessment of factors influencing health-related quality of life in HIV-infected patients.
- Published in:
- HIV Medicine, 2011, v. 12, n. 1, p. 22, doi. 10.1111/j.1468-1293.2010.00844.x
- By:
- Publication type:
- Article
Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure.
- Published in:
- HIV Medicine, 2011, v. 12, n. 1, p. 4, doi. 10.1111/j.1468-1293.2010.00855.x
- By:
- Publication type:
- Article
Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naïve HIV-infected patients Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naïve HIV-infected patients S Lambert-Niclot et al. Atazanavir inhibitory quotient in first-line therapy
- Published in:
- HIV Medicine, 2010, v. 11, n. 10, p. 666, doi. 10.1111/j.1468-1293.2010.00839.x
- By:
- Publication type:
- Article
Effect of simplification from protease inhibitors to boosted atazanavir-based regimens in real-life conditions.
- Published in:
- HIV Medicine, 2010, v. 11, n. 9, p. 545, doi. 10.1111/j.1468-1293.2010.00827.x
- By:
- Publication type:
- Article
Post-exercise heart rate recovery in HIV-positive individuals on highly active antiretroviral therapy. Early indicator of cardiovascular disease?
- Published in:
- HIV Medicine, 2008, v. 9, n. 2, p. 96, doi. 10.1111/j.1468-1293.2007.00524.x
- By:
- Publication type:
- Article
Low body weight and type of protease inhibitor predict discontinuation and treatment-limiting adverse drug reactions among HIV-infected patients starting a protease inhibitor regimen: consistent results from a randomized trial and an observational cohort.
- Published in:
- HIV Medicine, 2001, v. 2, n. 1, p. 43, doi. 10.1046/j.1468-1293.2001.00045.x
- By:
- Publication type:
- Article
The efficacy and safety of vildagliptin in patients with type 2 diabetes: a meta-analysis of randomized clinical trials.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2012, v. 37, n. 4, p. 386, doi. 10.1111/j.1365-2710.2011.01323.x
- By:
- Publication type:
- Article
Evolution of Therapy for Relapsed or Refractory Multiple Myeloma.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2020, v. 11, n. 1, p. 22
- Publication type:
- Article
Anti-retroviral therapy, insulin resistance and lipodystrophy.
- Published in:
- Diabetes, Obesity & Metabolism, 2001, v. 3, n. 2, p. 67, doi. 10.1046/j.1463-1326.2001.00146.x
- By:
- Publication type:
- Article
Podocyte directed therapy of nephrotic syndrome-can we bring the inside out?
- Published in:
- Pediatric Nephrology, 2016, v. 31, n. 3, p. 393, doi. 10.1007/s00467-015-3116-4
- By:
- Publication type:
- Article
Advances in diagnosing and managing antibody-mediated rejection.
- Published in:
- Pediatric Nephrology, 2010, v. 25, n. 10, p. 2035, doi. 10.1007/s00467-009-1386-4
- By:
- Publication type:
- Article
Therapeutic potential of proteasome inhibitors for dihydropyridine‐induced gingival overgrowth.
- Published in:
- Oral Diseases, 2020, v. 26, n. 3, p. 630, doi. 10.1111/odi.13260
- By:
- Publication type:
- Article
The Emerging Roles of Non-Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral Therapy.
- Published in:
- Drugs, 2001, v. 61, n. 1, p. 19, doi. 10.2165/00003495-200161010-00003
- By:
- Publication type:
- Article
Indinavir: A Review of its Use in the Management of HIV Infection.
- Published in:
- Drugs, 1999, v. 58, n. 6, p. 1165
- By:
- Publication type:
- Article